Venezuelan equine encephalitis vaccine (Vaxart)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVenezuelan equine encephalitis vaccine (Vaxart)

Drug Alias Namerecombinant adenovirus vector + E2E36K antigen + TLR-3 ligand vaccine (Vaxart)recombinant adenovirus vector vaccine (Vaxart)recombinant adenovirus vector + TLR-3 ligand vaccine (Vaxart)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionToll like receptor 3 agonists

TargetsToll like receptor 3

Therapy Area/IndicationsEncephalomyelitis, Venezuelan Equine

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVaxart Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaxart Biosciences Inc

Active IndicationsN/A

Inactive IndicationsEncephalomyelitis, Venezuelan Equine

Other Information

ATC CodeN/A